In January 2026, Vir Biotechnology reported new positive data from its ongoing SOLSTICE Phase 2 trial in chronic hepatitis delta, where combination therapy with investigational agents tobevibart and ...
Join a young traveler as she embarks on a peaceful sampan boat ride through Vietnam's breathtaking Mekong Delta. From wearing ...
Happening soon: You're Invited to Coastline Christian Info Day on the San Leandro Patch calendar ...
ETHealthworld.com brings latest takeda pharmaceutical news, views and updates from all top sources for the Indian Health industry.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results